Asha’s Story: Living With Pulmonary Fibrosis and Lupus

Phase 2 Clinical Trial For IPF Patients With Chronic Cough

Afferent Pharmaceuticals, a biotechnology company dedicated to therapies for neurogenic disorders, recently announced the beginning of a Phase 2 clinical trial to assess its candidate product AF-219 for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF). Neurogenic disorders are conditions associated with the…

Pulmonary Fibrosis Assessed Using Novel X-Ray Imaging Technique

In a recent study in the journal Scientific Reports, a team of researchers demonstrated the use of a new imaging modality that might detect and monitor fibrosis in the lungs of patients with pulmonary disorders and reduce the number of animals required for pulmonary research studies. The cause…

Emphysema Treatment – Pulmonary Fibrosis

Emphysema is a type of lung disease that causes shortness of breath. In a person with emphysema, the alveoli are damaged. The alveoli walls and the elastic fibers are damaged and lost.   Learn more about Emphysema and Pulmonary Fibrosis: http://bit.ly/1ONmRdG…

‘Organs on Chips’ May Revolutionize Lung, Other Disease Research

Researchers at the University of Miami (UM), led by Assistant Professor Ashutosh Agarwal, are developing functional organs able to mimic real human organs. These laboratory-developed structures, based on chips, could revolutionize approaches to disease treatment by allowing researchers to peer into organs and their related diseases. The research team used an innovative approach…

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums